Avalo Therapeutics, Inc. · NASDAQ:AVTX
Silverarc Capital Management, LLC's stake in Avalo Therapeutics, Inc. fell to 2.83% (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 10, 2026
Silverarc Capital Management, LLC's stake in Avalo Therapeutics, Inc. fell to 2.83%, 524,436 shares, as a passive investor on Dec 31, 2025. Filed Feb 10, 2026 (Schedule 13G).
- Stake
- 2.83%
- Shares
- 524,436
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SilverArc Capital Management, LLC | 2.83% | 524,436 |
| Devesh Gandhi | 2.83% | 524,436 |
Source
Related
- Avalo Therapeutics, Inc.
- Silverarc Capital Management, LLC
- Avalo Therapeutics, Inc. shareholders
- Schedule 13G · Silverarc Capital Management, LLC · Nov 14, 2025
- Form 4 · Sullivan Christopher Ryan · Sep 18, 2026
- Form 4 · Sullivan Christopher Ryan · Sep 11, 2026
- Form 4 · Doyle Mittie · Sep 1, 2026
- Form 4 · Sullivan Christopher Ryan · Aug 19, 2026
- Form 4 · Doyle Mittie · Aug 19, 2026